We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Drugs for Pain Management industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Generic Opioid
Branded Opioids
NSAIDs
Others
Market Segment by Product Application
Hospitals
Drugstores
Others
Finally, the report provides detailed profile and data information analysis of leading company.
GSK
Pfizer
Grunenthal
Sanofi
Bayer
AstraZeneca
Eli Lilly
Endo
Merck
Yunnan Baiyao
Teikoku Seiyaku
Teva
J&J
Assertio Therapeutics
Allergan
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Drugs for Pain Management consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Drugs for Pain Management market by identifying its various subsegments.
3.Focuses on the key global Drugs for Pain Management manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Drugs for Pain Management with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Drugs for Pain Management submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Drugs for Pain Management Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Drugs for Pain Management Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Drugs for Pain Management Segment by Type
2.1.1 Generic Opioid
2.1.2 Branded Opioids
2.1.3 NSAIDs
2.1.4 Others
2.2 Market Analysis by Application
2.2.1 Hospitals
2.2.2 Drugstores
2.2.3 Others
2.3 Global Drugs for Pain Management Market Comparison by Regions (2017-2027)
2.3.1 Global Drugs for Pain Management Market Size (2017-2027)
2.3.2 North America Drugs for Pain Management Status and Prospect (2017-2027)
2.3.3 Europe Drugs for Pain Management Status and Prospect (2017-2027)
2.3.4 China Drugs for Pain Management Status and Prospect (2017-2027)
2.3.5 Japan Drugs for Pain Management Status and Prospect (2017-2027)
2.3.6 Southeast Asia Drugs for Pain Management Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Drugs for Pain Management Industry Impact
2.5.1 Drugs for Pain Management Business Impact Assessment - Covid-19
2.5.2 Market Trends and Drugs for Pain Management Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Drugs for Pain Management Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Drugs for Pain Management Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Drugs for Pain Management Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Drugs for Pain Management Manufacturer Market Share
3.5 Top 10 Drugs for Pain Management Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Drugs for Pain Management Market
3.7 Key Manufacturers Drugs for Pain Management Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Drugs for Pain Management Industry Key Manufacturers
4.1 GSK
4.1.1 Compan Detail
4.1.2 GSK Drugs for Pain Management Product Introduction, Application and Specification
4.1.3 GSK 167 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 GSK News
4.2 Pfizer
4.2.1 Compan Detail
4.2.2 Pfizer Drugs for Pain Management Product Introduction, Application and Specification
4.2.3 Pfizer Drugs for Pain Management Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 GSK News
4.3 Grunenthal
4.3.1 Compan Detail
4.3.2 Grunenthal Drugs for Pain Management Product Introduction, Application and Specification
4.3.3 Grunenthal Drugs for Pain Management Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Grunenthal News
4.4 Sanofi
4.4.1 Compan Detail
4.4.2 Sanofi Drugs for Pain Management Product Introduction, Application and Specification
4.4.3 Sanofi Drugs for Pain Management Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Sanofi News
4.5 Bayer
4.5.1 Compan Detail
4.5.2 Sanofi Drugs for Pain Management Product Introduction, Application and Specification
4.5.3 Bayer Drugs for Pain Management Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Bayer News
4.6 AstraZeneca
4.6.1 Compan Detail
4.6.2 AstraZeneca Drugs for Pain Management Product Introduction, Application and Specification
4.6.3 AstraZeneca Drugs for Pain Management Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 AstraZeneca News
4.7 Eli Lilly
4.7.1 Compan Detail
4.7.2 Eli Lilly Drugs for Pain Management Product Introduction, Application and Specification
4.7.3 Eli Lilly Drugs for Pain Management Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Endo
4.8.1 Compan Detail
4.8.2 Endo Drugs for Pain Management Product Introduction, Application and Specification
4.8.3 Endo Drugs for Pain Management Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Endo News
4.9 Merck
4.9.1 Compan Detail
4.9.2 Merck Drugs for Pain Management Product Introduction, Application and Specification
4.9.3 Merck Drugs for Pain Management Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Merck News
4.10 Yunnan Baiyao
4.10.1 Compan Detail
4.10.2 Yunnan Baiyao Drugs for Pain Management Product Introduction, Application and Specification
4.10.3 Yunnan Baiyao Drugs for Pain Management Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Yunnan Baiyao News
4.11 Teikoku Seiyaku
4.11.1 Compan Detail
4.11.2 Teikoku Seiyaku Drugs for Pain Management Product Introduction, Application and Specification
4.11.3 Teikoku Seiyaku Drugs for Pain Management Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Teikoku Seiyaku News
4.12 Teva
4.12.1 Compan Detail
4.12.2 Teva Drugs for Pain Management Product Introduction, Application and Specification
4.12.3 Teva Drugs for Pain Management Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Teva News
4.13 J&J
4.13.1 Company Details
4.13.2 J&J Drugs for Pain Management Product Introduction, Application and Specification
4.13.3 J&J Drugs for Pain Management Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 J&J News
4.14 Assertio Therapeutics
4.14.1 Compan Detail
4.14.2 Assertio Therapeutics Drugs for Pain Management Product Introduction, Application and Specification
4.14.3 Assertio Therapeutics Drugs for Pain Management Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 Assertio Therapeutics News
4.15 Allergan
4.15.1 Compan Detail
4.15.2 Allergan Drugs for Pain Management Product Introduction, Application and Specification
4.15.3 Allergan Drugs for Pain Management Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 Allergan News
5 Global Drugs for Pain Management Market Segment by Big Type
5.1 Global Drugs for Pain Management Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Drugs for Pain Management Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Drugs for Pain Management Revenue and Market Share by Big Type (2017-2022)
5.2 Generic Opioid Sales Growth Rate and Price
5.2.1 Global Generic Opioid Sales Growth Rate (2017-2022)
5.2.2 Global Generic Opioid Price (2017-2022)
5.3 Branded Opioids Sales Growth Rate and Price
5.3.1 Global Branded Opioids Sales Growth Rate (2017-2022)
5.3.2 Global Branded Opioids Price (2017-2022)
5.4 NSAIDs Sales Growth Rate and Price
5.4.1 Global NSAIDs Sales Growth Rate (2017-2022)
5.4.2 Global NSAIDs Price (2017-2022)
5.5 Others Sales Growth Rate and Price
5.5.1 Global Others Sales Growth Rate (2017-2022)
5.5.2 Global Others Price (2017-2022)
6 Global Drugs for Pain Management Market Segment by Big Application
6.1 Global Drugs for Pain Management Sales Market Share by Big Application (2017-2022)
6.2 Hospitals Sales Growth Rate (2017-2022)
6.3 Drugstores Sales Growth Rate (2017-2022)
6.4 Others Sales Growth Rate (2017-2022)
7 Global Drugs for Pain Management Forecast
7.1 Global Drugs for Pain Management Revenue, Sales and Growth Rate (2022-2027)
7.2 Drugs for Pain Management Market Forecast by Regions (2022-2027)
7.2.1 North America Drugs for Pain Management Market Forecast (2022-2027)
7.2.2 Europe Drugs for Pain Management Market Forecast (2022-2027)
7.2.3 China Drugs for Pain Management Market Forecast (2022-2027)
7.2.4 Japan Drugs for Pain Management Market Forecast (2022-2027)
7.2.5 Southeast Asia Drugs for Pain Management Market Forecast (2022-2027)
7.2.6 Other Regions Drugs for Pain Management Market Forecast (2022-2027)
7.3 Drugs for Pain Management Market Forecast by Type (2022-2027)
7.3.1 Global Drugs for Pain Management Sales Forecast by Type (2022-2027)
7.3.2 Global Drugs for Pain Management Market Share Forecast by Type (2022-2027)
7.4 Drugs for Pain Management Market Forecast by Application (2022-2027)
7.4.1 Global Drugs for Pain Management Sales Forecast by Application (2022-2027)
7.4.2 Global Drugs for Pain Management Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Drugs for Pain Management Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Drugs for Pain Management Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Drugs for Pain Management
Figure Market Concentration Ratio and Market Maturity Analysis of Drugs for Pain Management
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Drugs for Pain Management Market Size by Big Type
Figure Global Market Share of Drugs for Pain Management by Big Type in 2021
Figure Generic Opioid Picture (2017-2022)
Figure Branded Opioids Picture (2017-2022)
Figure NSAIDs Picture (2017-2022)
Global Drugs for Pain Management Market Size by Big Application
Table Global Drugs for Pain Management Market Size by Application
Figure Global Drugs for Pain Management Market Share by Big Application in 2021
Figure Hospitals Picture
Figure Drugstores Picture
Figure Others Picture
Table Global Drugs for Pain Management Comparison by Regions (M USD) (2017-2027)
Figure Global Drugs for Pain Management Market Size (Million US$) (2017-2027)
Figure North America Drugs for Pain Management Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Drugs for Pain Management Revenue (Million US$) Growth Rate (2017-2027)
Figure China Drugs for Pain Management Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Drugs for Pain Management Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Drugs for Pain Management Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Drugs for Pain Management Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Drugs for Pain Management Sales by Manufacturer (2017-2022)
Figure Global Drugs for Pain Management Sales Market Share by Manufacturer in 2021
Table Global Drugs for Pain Management Revenue by Manufacturer (2017-2022)
Figure Global Drugs for Pain Management Revenue Market Share by Manufacturer in 2021
Table Global Drugs for Pain Management Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Drugs for Pain Management Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Drugs for Pain Management Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Drugs for Pain Management Market
Table Key Manufacturers Drugs for Pain Management Product Type
Table Mergers & Acquisitions Planning
Table GSK Company Profile
Table Drugs for Pain Management Product Introduction, Application and Specification of GSK
Table Drugs for Pain Management Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Pfizer Company Profile
Table Drugs for Pain Management Product Introduction, Application and Specification of Pfizer
Table Drugs for Pain Management Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer Recent Development
Table Grunenthal Company Profile
Table Drugs for Pain Management Product Introduction, Application and Specification of Grunenthal
Table Drugs for Pain Management Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Grunenthal Main Business
Table Grunenthal Recent Development
Table Sanofi Company Profile
Table Drugs for Pain Management Product Introduction, Application and Specification of Sanofi
Table Drugs for Pain Management Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sanofi Main Business
Table Sanofi Recent Development
Table Sanofi Main Business
Table Sanofi Recent Development
Table Bayer Company Profile
Table Drugs for Pain Management Product Introduction, Application and Specification of Bayer
Table Drugs for Pain Management Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bayer Main Business
Table Bayer Recent Development
Table AstraZeneca Company Profile
Table Drugs for Pain Management Product Introduction, Application and Specification of AstraZeneca
Table Drugs for Pain Management Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table Eli Lilly Company Profile
Table Drugs for Pain Management Product Introduction, Application and Specification of Eli Lilly
Table Drugs for Pain Management Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table Endo Company Profile
Table Drugs for Pain Management Product Introduction, Application and Specification of Endo
Table Drugs for Pain Management Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Endo Main Business
Table Endo Recent Development
Table Merck Company Profile
Table Drugs for Pain Management Product Introduction, Application and Specification of Merck
Table Drugs for Pain Management Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck Main Business
Table Merck Recent Development
Table Yunnan Baiyao Company Profile
Table Drugs for Pain Management Product Introduction, Application and Specification of Yunnan Baiyao
Table Drugs for Pain Management Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Yunnan Baiyao Main Business
Table Yunnan Baiyao Recent Development
Table Teikoku Seiyaku Company Profile
Table Drugs for Pain Management Product Introduction, Application and Specification of Teikoku Seiyaku
Table Drugs for Pain Management Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Teikoku Seiyaku Main Business
Table Teikoku Seiyaku Recent Development
Table Teva Company Profile
Table Drugs for Pain Management Product Introduction, Application and Specification of Teva
Table Drugs for Pain Management Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Teva Main Business
Table Teva Recent Development
Table J&J Company Profile
Table Drugs for Pain Management Product Introduction, Application and Specification of J&J
Table Drugs for Pain Management Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table J&J Main Business
Table J&J Recent Development
Table Assertio Therapeutics Company Profile
Table Drugs for Pain Management Product Introduction, Application and Specification of Assertio Therapeutics
Table Drugs for Pain Management Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Assertio Therapeutics Main Business
Table Assertio Therapeutics Recent Development
Figure Global Drugs for Pain Management Sales and Growth Rate (2017-2022)
Figure Global Drugs for Pain Management Revenue and Growth Rate (2017-2022)
Table Global Drugs for Pain Management Sales by Regions (2017-2022)
Figure Global Drugs for Pain Management Sales Market Share by Regions in 2021
Table Global Drugs for Pain Management Revenue by Regions (2017-2022)
Figure Global Drugs for Pain Management Revenue Market Share by Regions in 2021
Figure North America Drugs for Pain Management Sales and Growth Rate (2017-2022)
Figure Europe Drugs for Pain Management Sales and Growth Rate (2017-2022)
Figure China Drugs for Pain Management Sales and Growth Rate (2017-2022)
Figure Japan Drugs for Pain Management Sales and Growth Rate (2017-2022)
Figure Southeast Asia Drugs for Pain Management Sales and Growth Rate (2017-2022)
Figure Other Regions Drugs for Pain Management Sales and Growth Rate (2017-2022)
Table Global Drugs for Pain Management Sales by Big Type (2017-2022)
Table Global Drugs for Pain Management Sales Market Share by Big Type (2017-2022)
Figure Global Drugs for Pain Management Sales Market Share by Big Type in 2019
Table Global Drugs for Pain Management Revenue by Big Type (2017-2022)
Table Global Drugs for Pain Management Revenue Market Share by Big Type (2017-2022)
Table Global Drugs for Pain Management Revenue Market Share by Big Type in 2019
Figure Global Generic Opioid Sales Growth Rate (2017-2022)
Figure Global Generic Opioid Price (2017-2022)
Figure Global Branded Opioids Sales Growth Rate (2017-2022)
Figure Global Branded Opioids Price (2017-2022)
Figure Global NSAIDs Sales Growth Rate (2017-2022)
Figure Global NSAIDs Price (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Table Global Drugs for Pain Management Sales by Big Application (2017-2022)
Table Global Drugs for Pain Management Sales Market Share by Big Application (2017-2022)
Figure Global Drugs for Pain Management Sales Market Share by Big Application in 2019
Figure Global Hospitals Sales Growth Rate (2017-2022)
Figure Global Drugstores Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Drugs for Pain Management Sales and Growth Rate (2022-2027)
Figure Global Drugs for Pain Management Revenue and Growth Rate (2022-2027)
Table Global Drugs for Pain Management Sales Forecast by Regions (2022-2027)
Table Global Drugs for Pain Management Market Share Forecast by Regions (2022-2027)
Figure North America Sales Drugs for Pain Management Market Forecast (2022-2027)
Figure Europe Sales Drugs for Pain Management Market Forecast (2022-2027)
Figure China Sales Drugs for Pain Management Market Forecast (2022-2027)
Figure Japan Sales Drugs for Pain Management Market Forecast (2022-2027)
Figure Southeast Asia Sales Drugs for Pain Management Market Forecast (2022-2027)
Figure Other Regions Sales Drugs for Pain Management Market Forecast (2022-2027)
Table Global Drugs for Pain Management Sales Forecast by Type (2022-2027)
Table Global Drugs for Pain Management Market Share Forecast by Type (2022-2027)
Table Global Drugs for Pain Management Sales Forecast by Application (2022-2027)
Table Global Drugs for Pain Management Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Pain Management
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Drugs for Pain Management Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Drugs for Pain Management Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Drugs for Pain Management Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Drugs for Pain Management Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Drugs for Pain Management Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Drugs for Pain Management Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Drugs for Pain Management Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Drugs for Pain Management Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
GSK
Pfizer
Grunenthal
Sanofi
Bayer
AstraZeneca
Eli Lilly
Endo
Merck
Yunnan Baiyao
Teikoku Seiyaku
Teva
J&J